|
Name |
1,2-Dihydrohelvolic acid
|
Molecular Formula | C33H46O8 | |
IUPAC Name* |
(2Z)-2-[(4S,5S,6S,8S,9S,10R,13R,14S,16S)-6,16-diacetyloxy-4,8,10,14-tetramethyl-3,7-dioxo-2,4,5,6,9,11,12,13,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
|
|
SMILES |
C[C@H]1[C@@H]2[C@@H](C(=O)[C@]3([C@H]([C@]2(CCC1=O)C)CC[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)C)OC(=O)C
|
|
InChI |
InChI=1S/C33H46O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,18,22,24-25,27-28H,9,11-16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,24+,25+,27-,28+,31-,32+,33-/m1/s1
|
|
InChIKey |
ADRQWLCLPUQFJM-OAJDADRGSA-N
|
|
Synonyms |
1,2-Dihydrohelvolic acid; MEGxm0_000012; CHEMBL4648976
|
|
CAS | NA | |
PubChem CID | 23844015 | |
ChEMBL ID | CHEMBL4648976 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 570.7 | ALogp: | 4.9 |
HBD: | 1 | HBA: | 8 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 124.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 41 | QED Weighted: | 0.242 |
Caco-2 Permeability: | -5.359 | MDCK Permeability: | 0.00003900 |
Pgp-inhibitor: | 0.969 | Pgp-substrate: | 0.99 |
Human Intestinal Absorption (HIA): | 0.328 | 20% Bioavailability (F20%): | 0.025 |
30% Bioavailability (F30%): | 0.914 |
Blood-Brain-Barrier Penetration (BBB): | 0.951 | Plasma Protein Binding (PPB): | 94.12% |
Volume Distribution (VD): | 0.537 | Fu: | 8.85% |
CYP1A2-inhibitor: | 0.006 | CYP1A2-substrate: | 0.072 |
CYP2C19-inhibitor: | 0.01 | CYP2C19-substrate: | 0.499 |
CYP2C9-inhibitor: | 0.019 | CYP2C9-substrate: | 0.064 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.043 |
CYP3A4-inhibitor: | 0.223 | CYP3A4-substrate: | 0.253 |
Clearance (CL): | 3.92 | Half-life (T1/2): | 0.264 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.243 |
Drug-inuced Liver Injury (DILI): | 0.771 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.958 | Maximum Recommended Daily Dose: | 0.036 |
Skin Sensitization: | 0.064 | Carcinogencity: | 0.516 |
Eye Corrosion: | 0.966 | Eye Irritation: | 0.112 |
Respiratory Toxicity: | 0.975 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003848 | 0.905 | D0X7XG | 0.518 | ||||
ENC005153 | 0.803 | D0H2MO | 0.275 | ||||
ENC001480 | 0.787 | D08BDT | 0.270 | ||||
ENC005487 | 0.768 | D0X4RS | 0.270 | ||||
ENC003484 | 0.700 | D09IEE | 0.265 | ||||
ENC003780 | 0.654 | D0G7KJ | 0.263 | ||||
ENC005154 | 0.630 | D01ZOG | 0.256 | ||||
ENC005236 | 0.630 | D04SFH | 0.255 | ||||
ENC005155 | 0.625 | D0X2LV | 0.251 | ||||
ENC001478 | 0.518 | D09WYX | 0.247 |